Cargando…
EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality
The clinical experience recently reported with epidermal growth factor receptor (EGFR)-targeting drugs confirms the synergistic interactions observed between these compounds and conventional cytotoxic agents, which were previously established at the preclinical stage. There are, however, examples of...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453033/ https://www.ncbi.nlm.nih.gov/pubmed/18506149 http://dx.doi.org/10.1038/sj.bjc.6604373 |